[go: up one dir, main page]

AU2002357734A1 - Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer - Google Patents

Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer

Info

Publication number
AU2002357734A1
AU2002357734A1 AU2002357734A AU2002357734A AU2002357734A1 AU 2002357734 A1 AU2002357734 A1 AU 2002357734A1 AU 2002357734 A AU2002357734 A AU 2002357734A AU 2002357734 A AU2002357734 A AU 2002357734A AU 2002357734 A1 AU2002357734 A1 AU 2002357734A1
Authority
AU
Australia
Prior art keywords
cancer
methods
modulators
diagnosis
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002357734A
Inventor
Daniel Afar
Natasha Aziz
Wendy M. Ginsburg
Kurt C. Gish
Richard Glynne
Peter A. Hevezi
David H. Mack
Richard Murray
Susan R. Watson
Keith E. Wilson
Albert Zlotnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PDL Biopharma Inc
Original Assignee
Protein Design Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protein Design Labs Inc filed Critical Protein Design Labs Inc
Priority claimed from PCT/US2002/036810 external-priority patent/WO2003042661A2/en
Publication of AU2002357734A1 publication Critical patent/AU2002357734A1/en
Abandoned legal-status Critical Current

Links

AU2002357734A 2001-11-13 2002-11-13 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer Abandoned AU2002357734A1 (en)

Applications Claiming Priority (37)

Application Number Priority Date Filing Date Title
US35066601P 2001-11-13 2001-11-13
US60/350,666 2001-11-13
US33246401P 2001-11-21 2001-11-21
US60/332,464 2001-11-21
US33439301P 2001-11-29 2001-11-29
US60/334,393 2001-11-29
US33539401P 2001-12-03 2001-12-03
US60/335,394 2001-12-03
US34037601P 2001-12-14 2001-12-14
US60/340,376 2001-12-14
US34721102P 2002-01-08 2002-01-08
US60/347,211 2002-01-08
US34734902P 2002-01-10 2002-01-10
US60/347,349 2002-01-10
US35525002P 2002-02-08 2002-02-08
US60/355,250 2002-02-08
US35671402P 2002-02-13 2002-02-13
US60/356,714 2002-02-13
US35907702P 2002-02-20 2002-02-20
US60/359,077 2002-02-20
US36880902P 2002-03-29 2002-03-29
US60/368,809 2002-03-29
US37011002P 2002-04-04 2002-04-04
US60/370,110 2002-04-04
US37224602P 2002-04-12 2002-04-12
US60/372,246 2002-04-12
US38661402P 2002-06-05 2002-06-05
US60/386,614 2002-06-05
US39683902P 2002-07-16 2002-07-16
US60/396,839 2002-07-16
US39784502P 2002-07-22 2002-07-22
US39777502P 2002-07-22 2002-07-22
US60/397,845 2002-07-22
US60/397,775 2002-07-22
US40945002P 2002-09-09 2002-09-09
US60/409,450 2002-09-09
PCT/US2002/036810 WO2003042661A2 (en) 2001-11-13 2002-11-13 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer

Publications (1)

Publication Number Publication Date
AU2002357734A1 true AU2002357734A1 (en) 2003-05-26

Family

ID=32719847

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002357734A Abandoned AU2002357734A1 (en) 2001-11-13 2002-11-13 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer

Country Status (4)

Country Link
EP (1) EP1497454A2 (en)
JP (1) JP2005525789A (en)
AU (1) AU2002357734A1 (en)
CA (1) CA2467433A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229232A1 (en) * 2002-09-11 2004-11-18 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
PT2325305E (en) 2005-02-25 2014-04-29 Oncotherapy Science Inc Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
WO2008104803A2 (en) * 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Proteins
WO2009016691A1 (en) * 2007-07-30 2009-02-05 Oncotherapy Science, Inc. Cancer associated gene ly6k
NZ587506A (en) * 2008-01-25 2012-09-28 Univ Aarhus Selective exosite inhibition of papp-a activity against igfbp-4
JPWO2011115268A1 (en) * 2010-03-18 2013-07-04 大日本住友製薬株式会社 Tumor angiogenesis inhibitor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth

Also Published As

Publication number Publication date
CA2467433A1 (en) 2003-05-22
JP2005525789A (en) 2005-09-02
EP1497454A2 (en) 2005-01-19

Similar Documents

Publication Publication Date Title
AU2002309583A1 (en) Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
AU2002330039A1 (en) Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
AU2002245317A1 (en) Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
AU2002347428A1 (en) Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
AU2002215345A1 (en) Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
AU2002257004A1 (en) Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
WO2002068677A8 (en) Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer
AU2001231199A1 (en) Compositions and methods for the early diagnosis of ovarian cancer
AU2002249871A1 (en) Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2002316576A1 (en) Diagnostic and screening methods for bladder cancer
AU2002339865A1 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
WO2003022987A9 (en) Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection
AU2001290902A1 (en) Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
AU2003300368A1 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
AU3752700A (en) Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators
AU6902200A (en) Novel methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
AU3755300A (en) Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002364708A1 (en) Novel compositions and methods for cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2002357734A1 (en) Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase